SomnoMed Limited (SOM.AX)
AUD 0.43
(-18.87%)
AUD 0.43
(-18.87%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -12.24 Million AUD | -53.04% |
| 2023 | -7.99 Million AUD | -80.28% |
| 2022 | -4.43 Million AUD | -271.91% |
| 2021 | -1.19 Million AUD | -6.66% |
| 2020 | -1.11 Million AUD | -2739.95% |
| 2019 | -39.38 Thousand AUD | -101.7% |
| 2018 | 2.31 Million AUD | 169.28% |
| 2017 | -3.34 Million AUD | -2126.53% |
| 2016 | 165 Thousand AUD | -72.37% |
| 2015 | 597.22 Thousand AUD | 47.15% |
| 2014 | 405.86 Thousand AUD | -31.07% |
| 2013 | 588.79 Thousand AUD | 12.22% |
| 2012 | 524.68 Thousand AUD | -29.05% |
| 2011 | 739.53 Thousand AUD | -5.93% |
| 2010 | 786.14 Thousand AUD | 143.23% |
| 2009 | -1.81 Million AUD | 33.41% |
| 2008 | -2.73 Million AUD | 16.59% |
| 2007 | -3.27 Million AUD | 21.82% |
| 2006 | -4.18 Million AUD | -28.21% |
| 2005 | -3.26 Million AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -12.24 Million AUD | -53.04% |
| 2024 Q4 | -5.89 Million AUD | 0.0% |
| 2024 Q2 | -6.34 Million AUD | 0.0% |
| 2023 Q4 | -4.25 Million AUD | 0.0% |
| 2023 Q2 | -3.74 Million AUD | 0.0% |
| 2023 FY | -7.99 Million AUD | -80.28% |
| 2022 Q2 | -2.94 Million AUD | 0.0% |
| 2022 Q4 | -1.48 Million AUD | 0.0% |
| 2022 FY | -4.43 Million AUD | -271.91% |
| 2021 FY | -1.19 Million AUD | -6.66% |
| 2021 Q2 | 491.57 Thousand AUD | 0.0% |
| 2021 Q4 | -1.68 Million AUD | 0.0% |
| 2020 Q2 | 766.43 Thousand AUD | 0.0% |
| 2020 Q4 | -1.88 Million AUD | 0.0% |
| 2020 FY | -1.11 Million AUD | -2739.95% |
| 2019 Q4 | 3057.00 AUD | 0.0% |
| 2019 FY | -39.38 Thousand AUD | -101.7% |
| 2019 Q2 | -42.44 Thousand AUD | 0.0% |
| 2018 FY | 2.31 Million AUD | 169.28% |
| 2018 Q2 | -1 Million AUD | 0.0% |
| 2018 Q4 | 3.32 Million AUD | 0.0% |
| 2017 Q2 | -600.58 Thousand AUD | 0.0% |
| 2017 FY | -3.34 Million AUD | -2126.53% |
| 2017 Q4 | -2.74 Million AUD | 0.0% |
| 2016 Q2 | 178.52 Thousand AUD | 0.0% |
| 2016 Q4 | -13.52 Thousand AUD | 0.0% |
| 2016 FY | 165 Thousand AUD | -72.37% |
| 2015 FY | 597.22 Thousand AUD | 47.15% |
| 2015 Q4 | 537.41 Thousand AUD | 0.0% |
| 2015 Q2 | 59.8 Thousand AUD | 0.0% |
| 2014 FY | 405.86 Thousand AUD | -31.07% |
| 2014 Q4 | 566.46 Thousand AUD | 0.0% |
| 2014 Q2 | -160.6 Thousand AUD | 0.0% |
| 2013 Q2 | 191.5 Thousand AUD | 0.0% |
| 2013 FY | 588.79 Thousand AUD | 12.22% |
| 2013 Q4 | 397.28 Thousand AUD | 0.0% |
| 2012 Q4 | 131.17 Thousand AUD | 0.0% |
| 2012 Q1 | 184.88 Thousand AUD | 0.0% |
| 2012 Q3 | 131.17 Thousand AUD | 0.0% |
| 2012 FY | 524.68 Thousand AUD | -29.05% |
| 2012 Q2 | 131.17 Thousand AUD | -29.05% |
| 2011 FY | 739.53 Thousand AUD | -5.93% |
| 2011 Q1 | 196.53 Thousand AUD | 0.0% |
| 2011 Q2 | 184.88 Thousand AUD | -5.93% |
| 2011 Q3 | 184.88 Thousand AUD | 0.0% |
| 2011 Q4 | 184.88 Thousand AUD | 0.0% |
| 2010 Q4 | 196.53 Thousand AUD | 0.0% |
| 2010 Q1 | -454.66 Thousand AUD | 0.0% |
| 2010 Q2 | 196.53 Thousand AUD | 143.23% |
| 2010 Q3 | 196.53 Thousand AUD | 0.0% |
| 2010 FY | 786.14 Thousand AUD | 143.23% |
| 2009 Q1 | -682.77 Thousand AUD | 0.0% |
| 2009 Q3 | -454.66 Thousand AUD | 0.0% |
| 2009 Q4 | -454.66 Thousand AUD | 0.0% |
| 2009 FY | -1.81 Million AUD | 33.41% |
| 2009 Q2 | -454.66 Thousand AUD | 33.41% |
| 2008 Q4 | -682.77 Thousand AUD | 0.0% |
| 2008 Q3 | -682.77 Thousand AUD | 0.0% |
| 2008 Q2 | -682.77 Thousand AUD | 16.59% |
| 2008 Q1 | -818.59 Thousand AUD | 0.0% |
| 2008 FY | -2.73 Million AUD | 16.59% |
| 2007 Q1 | -1.04 Million AUD | 0.0% |
| 2007 FY | -3.27 Million AUD | 21.82% |
| 2007 Q3 | -818.59 Thousand AUD | 0.0% |
| 2007 Q4 | -818.59 Thousand AUD | 0.0% |
| 2007 Q2 | -818.59 Thousand AUD | 21.82% |
| 2006 Q3 | -1.04 Million AUD | 0.0% |
| 2006 Q2 | -1.04 Million AUD | -28.21% |
| 2006 Q4 | -1.04 Million AUD | 0.0% |
| 2006 FY | -4.18 Million AUD | -28.21% |
| 2006 Q1 | -816.65 Thousand AUD | 0.0% |
| 2005 Q4 | -816.65 Thousand AUD | 0.0% |
| 2005 FY | -3.26 Million AUD | 0.0% |
| 2005 Q3 | -816.65 Thousand AUD | 0.0% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q2 | -816.65 Thousand AUD | 0.0% |
| 2004 Q2 | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2004 Q3 | - AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 65.975% |
| Adherium Limited | -10.22 Million AUD | -19.733% |
| Aroa Biosurgery Limited | -9.74 Million AUD | -25.578% |
| Atomo Diagnostics Limited | -6.84 Million AUD | -78.769% |
| Anteris Technologies Ltd | -67.33 Million AUD | 81.819% |
| Control Bionics Limited | -5.91 Million AUD | -107.003% |
| CardieX Limited | -6.76 Million AUD | -80.947% |
| Compumedics Limited | -338 Thousand AUD | -3521.812% |
| Cochlear Limited | 356.8 Million AUD | 103.431% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -291.467% |
| Cyclopharm Limited | -4.7 Million AUD | -160.418% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -348.479% |
| Nova Eye Medical Limited | -8.79 Million AUD | -39.269% |
| HeraMED Limited | -6.78 Million AUD | -80.459% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 45.895% |
| ImpediMed Limited | -19.79 Million AUD | 38.142% |
| InhaleRx Limited | -1.44 Million AUD | -748.193% |
| LBT Innovations Limited | -3.74 Million AUD | -227.319% |
| Micro-X Limited | -9.76 Million AUD | -25.363% |
| Neurotech International Limited | -5.06 Million AUD | -141.49% |
| OncoSil Medical Limited | -11.91 Million AUD | -2.754% |
| PolyNovo Limited | 5.26 Million AUD | 332.688% |
| Respiri Limited | -7.12 Million AUD | -71.711% |
| Universal Biosensors, Inc. | -6.74 Million AUD | -81.586% |
| Uscom Limited | -2.07 Million AUD | -490.034% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -141.773% |